Cancer BiologybioRxivPreprint
The Salt-Inducible Kinase inhibitor YKL-05-099 suppresses MEF2C function and acute myeloid leukemia progression in vivo
Yusuke Tarumoto, Shan Lin, Jinhua Wang…·Christopher R. Vakoc
This study shows that the SIK3 inhibitor YKL-05-099 suppresses MEF2C function and slows AML progression in mouse models.
DOI 10.1101/636969